IMDZ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
IMDZ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immune Design's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2018 was $0.00 Mil.
The historical data trend for Immune Design's Long-Term Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Immune Design Annual Data | ||||||||||||||||
Trend | Dec12 | Dec13 | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | |||||||||
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | - | - | - | - | - |
Immune Design Quarterly Data | ||||||||||||||||||||
Mar14 | Jun14 | Sep14 | Dec14 | Mar15 | Jun15 | Sep15 | Dec15 | Mar16 | Jun16 | Sep16 | Dec16 | Mar17 | Jun17 | Sep17 | Dec17 | Mar18 | Jun18 | Sep18 | Dec18 | |
Long-Term Capital Lease Obligation | Get a 7-Day Free Trial | - | - | - | - | - |
Immune Design (NAS:IMDZ) Long-Term Capital Lease Obligation Explanation
Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.
Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:
1. Ownership of the asset is transferred to the lessee at the end of the lease term;Thank you for viewing the detailed overview of Immune Design's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
William R Ringo | director | |
David Baltimore | director | AMGEN INC., ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799 |
Edward Penhoet | director | ONE EMBARCADERO CENTER SUITE 3700, SAN FRANCISCO CA 94111 |
Susan L. Kelley | director | C/O DECIPHERA PHARMACEUTICALS, INC., 200 SMITH STREET, WALTHAM MA 02451 |
Carlos V Paya | director, officer: President and CEO | C/O IMMUNE DESIGN CORP., 1616 EASTLAKE AVE. E, SUITE 310, SEATTLE WA 98102 |
David V Goeddel | 10 percent owner, other: Managing Partner | C/O COLUMN GROUP LP, 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Column Group Ii, Lp | 10 percent owner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Peter Svennilson | 10 percent owner, other: Managing Partner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Tim Kutzkey | 10 percent owner, other: Managing Partner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Column Group Ii Gp, Lp | 10 percent owner, other: General Partner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Ponoi Capital, Lp | 10 percent owner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Ponoi Management, Llc | 10 percent owner, other: General Partner | 1 LETTERMAN DRIVE, BUILDING D, SUITE M-900, SAN FRANCISCO CA 94129 |
Column Group L P | 10 percent owner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Column Group Gp, Lp | 10 percent owner, other: General Partner | 1700 OWENS STREET, SUITE 500, SAN FRANCISCO CA 94158 |
Franklin M Berger | director | 1000 MARINA BLVD, STE 200, BRISBANE CA 94005 |
From GuruFocus
By Marketwired Marketwired • 05-03-2018
By Marketwired Marketwired • 02-22-2019
By Marketwired Marketwired • 12-02-2018
By Marketwired Marketwired • 10-12-2018
By Marketwired Marketwired • 11-20-2018
By Marketwired Marketwired • 08-02-2018
By Marketwired Marketwired • 04-25-2018
By Marketwired Marketwired • 11-09-2018
By Kyle Ferguson Kyle Ferguson • 10-03-2016
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.